(Q47976445)

7 February 2018

title

Detection of allosteric kinase inhibitors by displacement of active site probes (English)

1 reference

7 February 2018

1 reference

Connie S Lebakken

1

1 reference

7 February 2018

Laurie J Reichling

series ordinal

2

1 reference

7 February 2018

Jason M Ellefson

series ordinal

3

1 reference

7 February 2018

Steven M Riddle

series ordinal

4

1 reference

7 February 2018

publication date

26 March 2012

1 reference

7 February 2018

Journal of Biomolecular Screening

published in

1 reference

7 February 2018

volume

17

1 reference

7 February 2018

issue

6

1 reference

7 February 2018

page(s)

813-821

1 reference

7 February 2018

MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1087057112439889

Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057112439889

Allosteric inhibitors of Bcr-abl-dependent cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057112439889

N-myristoylated c-Abl tyrosine kinase localizes to the endoplasmic reticulum upon binding to an allosteric inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057112439889

Conformational disturbance in Abl kinase upon mutation and deregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057112439889

Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057112439889

Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platform.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057112439889

Fluorescent cascade and direct assays for characterization of RAF signaling pathway inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057112439889

Expression and purification of phosphorylated and non-phosphorylated human MEK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057112439889

Enzyme kinetics and binding studies on inhibitors of MEK protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057112439889

PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057112439889

Allosteric interactions between the myristate- and ATP-site of the Abl kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057112439889

Classifying protein kinase structures guides use of ligand-selectivity profiles to predict inactive conformations: structure of lck/imatinib complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057112439889

Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057112439889

21 January 2018

Identifiers

DOI

10.1177/1087057112439889

1 reference

7 February 2018

release_puytvtfhavfeffe2xv64vnwbqe

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/puytvtfhavfeffe2xv64vnwbqe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

7 February 2018